CNSY
Plus Therapeutics, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$2.78
−6.71%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.34x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.86x
- Price / sales
- 5.02x
- Price / cash flow
- -0.95x
Enterprise value
- Enterprise value
- $12.6M
- EV / sales
- 2.99x
- EV / EBITDA
- -0.56x
- EV / EBIT
- -0.48x
- Market cap
- $21.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026